Podcast Episodes
Back to SearchVox Royalty (TSX: VOXR) (NASDAQ: VOXR): Value Play in the Mining Royalty Space
Episode 377
My guest on the show today is Kyle Floyd, Chairman and CEO of Vox Royalty Corp. (TSX: VOXR) (NASDAQ: VOXR). Vox is a returns focused mining royalty c…
2 years, 5 months ago
Quirky / Off the Beaten Path Investing, Making Your Move + $PLCE $NCMI with David Bastian, Chief Investment Officer at Kingdom Capital Advisors
Episode 376
My guest on the show today is David Bastian, Chief Investment Officer of Kingdom Capital Advisors. I met David at Ian Cassel's MicroCap Leadership Su…
2 years, 5 months ago
The Case for Japanese MicroCaps with David Baeckelandt, Head of Client Relations at SuMi TRUST
Episode 375
My guest on the show today is David Baeckelandt, Head of Client Relations SuMi TRUST - the U.S. arm for Sumitomo Mitsui Trust Asset Management, Inc. …
2 years, 5 months ago
UGE International (TSX-V: UGE) (OTCQB: UGEIF): Develops Midscale Solar and Energy Storage Project
Episode 374
My guest on the show today is Nick Blitterswyk, CEO of UGE International Ltd. (TSXV: UGE) (OTCQB: UGEIF). UGE develops, owns, and operates commercial…
2 years, 5 months ago
State of the Junior Mining Market + Tools for the Modern Junior Mining Investor with Tavi Costa (Crescat Capital) / Emily King (Prospector Portal) / Steven De Jong (VRIFY)
Episode 373
On the quick trip to Beaver Creek, I had the opportunity to moderate a panel titled, "Tools for the Modern Junior Mining Investor." Thank you again t…
2 years, 6 months ago
VANCOUVER 2023 Investor Keynotes with Paul Andreola / Dave Barr / Harold Leishman / Ryan Irvine / Hamed Shahbazi / Brent Todd
Episode 372
For this episode, I compiled all the investor keynotes into one extra long audio episode for you to consume (each individual keynote is on the Planet…
2 years, 6 months ago
BioSyent (TSX-V: RX): Specialty Pharmaceutical Company Focused on Commercializing Assets in Canada
Episode 371
My guest on the show today is Rene Goehrum, President, CEO and Chairman of BioSyent (TSX-V: RX). BioSyent is a specialty pharmaceutical company focus…
2 years, 6 months ago
What the Data Says the Market Hates Right Now + One Semi-Bold Prediction with Tobias Carlisle, Founder and Managing Director of Acquirers Funds and Co-Host, Value After Hours
Episode 370
My guest on the show today is Tobias Carlisle, Founder and Managing Director of Acquirers Funds and Co-Host, Value After Hours. It's been well over a…
2 years, 6 months ago
BK Technologies (NYSE American: BKTI): Wireless Radio Communications Equipment for the Public Safety Market
Episode 369
My guest on the show today is John Suzuki, CEO of BK Technologies Corporation (NYSE American: BKTI). BK Technologies Corporation, through its operat…
2 years, 6 months ago
Revisiting ”MicroCaps” White Paper, International MicroCaps and Industrials/Tech/Consumer Sector Takes with Donald Porter, Portfolio Manager
Episode 368
My guest on the show today is Donald Porter, Portfolio Manager and most recently an Equity Research Analyst at Wellington Management. I am extremely …
2 years, 6 months ago